Scientists cannot watch a human brain slowly develop inside a person’s head, so they build miniature models in the lab. These models, known as brain organoids, are tiny clusters of brain cells that mimic some of the earliest stages of brain development.
The process begins with skin cells donated by volunteers. In the lab, researchers reprogram those cells into a stem-cell-like state and expose them to chemical signals that encourage them to form brain tissue. Within weeks, the cells develop into neurons and supporting cells and then assemble into round, lentil-sized blobs.
At Harvard, one research group sustained organoids for about seven years. When the organoids are young, their electrical activity resembles that of a very early infant brain. As they mature, their gene expression and signaling patterns shift to mirror those seen in a toddler’s brain. By freezing and analyzing organoids at different stages, scientists can map how brain tissue changes in its development.
These mini-brains also offer a window into neurological and developmental conditions. To investigate autism or rare genetic disorders, scientists grow organoids using cells from people with those diagnoses. Some of these organoids show misplaced neurons or unusual network patterns, giving clues about what may occur in the human brain.
Other labs place organoids on chips equipped with tiny metal electrodes that allow computers to send and receive electrical signals. In one project, called Brainoware, this setup enabled a computer system to learn how to classify simple speech sounds, such as different vowel tones.
As the technology advances, scientists are debating limits. Questions about how large organoids should grow, how they should be used in medicine or computing, and what safeguards are needed have been posed. The challenge is to support scientific progress while ensuring ethical boundaries remain clear.